Compare YHC & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YHC | GCTK |
|---|---|---|
| Founded | 2021 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 2.5M |
| IPO Year | 2023 | 2011 |
| Metric | YHC | GCTK |
|---|---|---|
| Price | $1.64 | $0.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 232.7K | ★ 18.2M |
| Earning Date | 04-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | ★ $1,120,622.00 | $589,462.00 |
| Revenue This Year | $1,267.57 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | ★ 86.42 | N/A |
| 52 Week Low | $0.02 | $0.25 |
| 52 Week High | $2.72 | $14.14 |
| Indicator | YHC | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 51.36 | 46.56 |
| Support Level | $0.72 | $0.28 |
| Resistance Level | $2.20 | $0.68 |
| Average True Range (ATR) | 0.26 | 0.13 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 41.48 | 19.09 |
LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.